Short communication · 4 Aug 2026
Conference abstractPublished 14 Nov 2016
The underutilization of therapeutic hypothermia after cardiac arrest
University of South Florida, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Approximately 500,000 people every year experience a cardiac arrest, of whom less than 10% are resuscitated. Survivors often encounter neurologic sequelae ranging from moderate cognitive dysfunction to brain death. The only treatment known to protect the brain from injury after a cardiac arrest is therapeutic hypothermia. Mild hypothermia may decrease the area of injury, promote epicardial reflow, decrease myocardial metabolic demand, and preserve intracellular high-energy phosphate stores. A 2011 meta-analysis of randomized controlled trials found that therapeutic hypothermia with conventional cooling methods improves both survival and neurologic outcomes at hospital discharge for patients who experienced cardiac arrest. While the process of therapeutic hypothermia is cost efficient and relatively easy to provide, only about 13% of hospitals offer this treatment. The Hypothermia after Cardiac Arrest Study Group showed that, when applied to unconscious outof- hospital cardiac arrest patients with return of spontaneous circulation (n=274), mild hypothermia (cooling to 32-34Ã?ºC) provided significant improvement in functional recovery at hospital discharge (55% vs 39%; number needed to treat (NNT=6) and lower 6-month mortality rate when compared with patients who were not cooled (41% vs 55%) (NNT=7). Despite the inclusion of hypothermia in American Heart Association Guidelines for CPR and Emergency Cardiovascular Care in 2005, mild therapeutic hypothermia has lacked sufficient weight and is largely misunderstood and inconsistently applied. Barriers such as lack of equipment, education, and protocols have been attributed to its underutilization. Therefore, hospitals need to be proactively involved and create protocols to defend its underutilization to protect vital organs.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical and Experimental Cardiology.
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Shawn W Blouin”
